
Orthofix International (OFIX) Stock Forecast & Price Target
Orthofix International (OFIX) Analyst Ratings
Bulls say
Orthofix Medical is poised for growth in the medical device industry due to its diverse product portfolio, with the majority of its revenue coming from the profitable Global Spine segment. This segment has a strong track record of delivering innovative and highly sought-after solutions for spinal procedures, making it a key driver for the company's success. Additionally, the company's focus on digital technologies for limb reconstruction in its Global Limb Reconstruction segment further showcases its commitment to staying ahead of the curve and sustaining long-term growth.
Bears say
Orthofix Medical is facing potential challenges due to a recent 10% reimbursement cut, as well as the unusual and rushed reclassification of bone growth stimulator devices to Class II. Additionally, the company's recent strategic realignment, including eliminating a leadership role and combining other segments under one leader, may lead to disruptions and uncertainties within the organization. These factors may negatively impact the company's financial performance and growth potential, leading to a negative outlook on its stock.
This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.
Orthofix International (OFIX) Analyst Forecast & Price Prediction
Start investing in Orthofix International (OFIX)
Order type
Buy in
Order amount
Est. shares
0 shares